Olink Proteomics is dedicated to innovation, quality, rigor and transparency, providing outstanding solutions and support for human protein biomarker discovery.
In a few short years, Olink has grown rapidly from a small, Sweden-based company offering assay for a few hundred proteins, to a NASDAQ-listed organization with a strong global presence, a broad portfolio of flexible protein biomarker solutions and library of high quality, thoroughly validated assays that cover ~3000 proteins.
Olink Proteomics was forged from a history of proteomics innovation and development that took place here in Uppsala. Read on to find out how this innovation influenced the creation of PEA and how Olink continues to honor this spirit today.

The promise of proteomics: Together with our customers, Olink is accelerating proteomics to better understand human biology and develop future healthcare. We are on a journey to explore the low-abundance plasma proteome to uncover actionable insights that can drive the development of precision medicine.